The NHCS Structural Heart Disease Programme is one of the leading programmes in the region to help treat and manage patients with structural heart disease. These include the treatment of patients with valvular heart disease (leaky and tight valves) as well as those with abnormalities in the structure of the heart.
NHCS was the first centre in the region to perform Transcatheter Aortic Valve Implantation (TAVI) for the treatment of aortic stenosis and MitraClip for the treatment of mitral regurgitation. In addition, the team provides a wide range of other therapies such as percutaneous tricuspid regurgitation treatment (TriClip and TriValve), PTMC, left atrial appendage closure, paravalvular leak closure, valve-in-valve therapies, amongst others.
The team comprises domain experts from various disciplines such as surgeons, interventional cardiologists, imaging cardiologists, nurses and allied health staff working together to ensure improved clinical outcomes in our patients.
Read more about the various treatments below:
New Minimally Invasive Treatments Offered In NHCS Offer Hope For Patients With Severe Heart Valve Disease
Chief Executive Officer & Senior Consultant, Department of Cardiology
Clinical Interest:
Emeritus Consultant, Department of Cardiology
View Profile
Deputy Chief Executive Officer & Senior Consultant, Department of Cardiology
Deputy Head and Senior Consultant, Department of Cardiology
Director, Echocardiography
Senior Consultant, Department of Cardiology
Advisor, Cardiac Catheterisation Laboratory
Director, Adult Congenital Heart Disease Programme
Co-Director, Adult Congenital Heart Disease Programme
Director, Structural Heart Interventions
Consultant, Department of Cardiology
Clinical Interests:
Associate Consultant, Department of Cardiology
Deputy Head (Thoracic) & Senior Consultant, Department of Cardiothoracic Surgery
Senior Consultant, Department of Cardiothoracic Surgery
Consultant, Department of Cardiothoracic Surgery
Subscribe to our mailing list to get the updates to your email inbox...
